Shenzhen RuiJin Pharmaceutical Co.,Ltd 86-188-06592208 Gavin@hgh-steroid.com
DXM Raw Pharmaceutical Steroid Dextromethorphan Hydrobromide For Weight Loss

DXM Raw Pharmaceutical Steroid Dextromethorphan Hydrobromide For Weight Loss

  • High Light

    pharma raw material

    ,

    Pharmaceutical Raw Materials

  • Product name
    Dextromethorphan Hydrobromide
  • Other Name
    Romilar
  • CAS 
    125-69-9
  • Molecular formula
    C18H26BrNO
  • Molecular weight
    352.31
  • Appearance
    White Powder
  • Standard
    Enterprise Standard/ ISO9001
  • Place of Origin
    China
  • Brand Name
    RuiiJin
  • Certification
    ISO9001
  • Model Number
    125-69-9
  • Minimum Order Quantity
    10g
  • Price
    Negotiable
  • Packaging Details
    Disguised package or according to your requirement
  • Delivery Time
    Within 3-5 days
  • Payment Terms
    Western union and moneygram,Bank transfer,Bitcoin, T/T
  • Supply Ability
    3000t/month

DXM Raw Pharmaceutical Steroid Dextromethorphan Hydrobromide For Weight Loss

DXM Raw Pharmaceutical Steroid Dextromethorphan Hydrobromide For Weight Loss

 

Quick Detail:

 

Dextromethorphan Hydrobromide
Alias: Romilar
CAS No.: 125-69-9
EINECS No.: 204-750-1
MF: C18H26BrNO
MW: 352.31
Purity: 99.0%

DXM Raw Pharmaceutical Steroid Dextromethorphan Hydrobromide For Weight Loss 0
Appearance: White or kind of white crystalline powder, soluble in water.

 

 

Description:

 

Medical use

 

Generic Dextromethorphan syrup.

The primary use of dextromethorphan is as a cough suppressant, for the temporary relief of cough caused by minor throat and bronchial irritation (such as commonly accompanies the flu and common cold), as well as those resulting from inhaled particle irritants.

 

A 2004 study showed that dextromethorphan was no more effective for children than a placebo.Studies conducted by the American Academy of Pediatrics show that dextromethorphan is not superior to a placebo in providing nocturnal symptom relief for children with cough and sleep difficulty due to upper respiratory infections.

 

A combination of dextromethorphan and quinidine, a CYP2D6 inhibitor, has been shown to alleviate symptoms of easy laughing and crying (pseudobulbar affect) in patients with amyotrophic lateral sclerosis and multiple sclerosis.Dextromethorphan is also being investigated as a possible treatment for neuropathic pain and pain associated with fibromyalgia.In 2010, the FDA approved the combination product dextromethorphan/quinidine (Nuedexta) for the treatment of pseudobulbar affect (PBA)

 

 

Application :

 

DXM is also used recreationally. When exceeding label-specified maximum dosages, dextromethorphan acts as a dissociative hallucinogen. Its mechanism of action is via multiple effects, including actions as a nonselective serotonin reuptake inhibitor and a sigma-1 receptor agonist. The major metabolite of DXM, dextrorphan, also acts as an NMDA receptor antagonist. In high doses this produces effects similar to, yet distinct from, the dissociative states created by other dissociative anaesthetic such as ketamine and phencyclidine. As well, the metabolite 3-methoxymorphinan of dextrorphan (thus a second-level metabolite of DXM) produces local anesthetic effects in rats with potency above dextrorphan, but below that of DXM.

 

 

Specifications:

 

Test Items Specification Test Results
Appearance white or almost white crystalline powder, slightly smelly white crystalline powder
Melting point 123~127℃ 123~125℃
Specific Rotation +28°~+30° +29°
Acidity(PH) 5.2~6.5 5.8~6.2
Water 4.0%~5.5% 5.0%
Residue On Ignition Not more than 0.1% Conforms
N.N - dimethylaniline Comply with the standard Conforms
Phenolic Compounds Comply with the standard Conforms
Related Substance Comply with the standard Conforms
Assay Between99.0~102.0% 99.53%
Conclusion This batch is complies with USP 34.